𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Complete remission in a patient with acute myelogenous leukemia treated with leukocyte α-interferon and cimetidine

✍ Scribed by Jaro Ankerst; Roger Fäldt; P. G. Nilsson; Per Flodgren; H. O. Sjögren

Publisher
Springer-Verlag
Year
1984
Tongue
English
Weight
300 KB
Volume
17
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cutaneous sarcoidosis in a patient with
Cutaneous sarcoidosis in a patient with philadelphia-positive chronic myelogenous leukemia treated with interferon-α
✍ Yavorkovsky, Leonid L.; Carrum, George; Bruce, Suzanne; McCarthy, Philip L. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 17 KB 👁 3 views

A patient with Philadelphia-positive (Ph+) chronic myelogenous leukemia (CML) was diagnosed with cutaneous sarcoidosis after treatment with interferon-alpha (IFN-␣). Following IFN-␣ dose reduction, the skin lesions disappeared. Few cases of sarcoidosis associated with IFN treatment have been reporte

A pilot study of interleukin-2 for adult
A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission
✍ Jorge E. Cortes; Hagop M. Kantarjian; Susan O'Brien; Francis Giles; Michael J. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## BACKGROUND. Interleukin-2 (IL-2) has immunomodulatory effects, including stimulating the activity of cytotoxic T cells and natural killer cells, and inducing the generation of lymphokine-activated killer cells. The authors investigated whether IL-2 may improve the duration of complete remission